Plain-English translation of NCT07223008 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Migraine research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a procedure called embolization using a product called Onyx to block two small blood vessels in the brain (the middle meningeal arteries) in people with severe chronic migraines that haven't responded to standard treatments. The theory is that by plugging these blood vessels, the brain releases fewer chemicals that trigger migraines. This treatment is not yet approved for migraines, though it is currently used for other brain conditions.
Many people with chronic migraines do not get relief from available medications, leaving them with persistent, disabling headaches. This trial is exploring whether this new approach โ blocking specific blood vessels โ might offer hope for patients who have already tried multiple standard migraine preventive treatments without success.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will undergo the embolization procedure, which uses special imaging to guide a tiny catheter to the target blood vessels in your brain where the Onyx material is injected to create a plug. Your participation will last about 8 months total, with 6 months of follow-up appointments after the procedure. You will need to keep a daily headache diary, continue taking your regular migraine medications, attend several clinic visits, and provide blood samples for research purposes.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
United States